ImmunoGen, Inc.

IMGN · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$605,535$571,987$201,249$275,138
Short-Term Investments$0$0$0$0
Receivables$130,694$79,964$31,046$17,978
Inventory$5,495$3,233$614-$28,983
Other Curr. Assets$22,150$14,089$10,955$11,005
Total Curr. Assets$736,229$571,987$201,249$275,138
Property Plant & Equip (Net)$17,227$12,773$13,694$14,608
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$68,645$129,567$73,402$59,190
Total NC Assets$85,872$142,340$87,096$73,798
Other Assets$0$0$0$0
Total Assets$822,101$714,327$288,345$348,936
Liabilities
Payables$24,853$18,441$32,260$45,353
Short-Term Debt-$24,853$4,334$4,213$4,096
Tax Payable$0$0$0$0
Deferred Revenue$37,186$14,389$13,444$13,856
Other Curr. Liab.$97,474$56,538$51,712$58,553
Total Curr. Liab.$134,660$93,702$101,629$121,858
LT Debt$72,113$71,957$10,049$11,148
Deferred Rev, NC$26,718$30,217$34,055$36,355
Deferred Tax Liab, NC$0$0$0-$11,148
Other NC Liab.$27,014$27,609$20,694$34,897
Total NC Liab.$125,845$129,783$64,798$71,252
Other Liabilities$0$0$0$0
Cap. Leases$7,759$13,254$14,262$15,244
Total Liabilities$260,505$223,485$166,427$193,110
Equity
Pref Stock$0$0$0$0
Common Stock$2,435$2,374$2,261$2,260
Retained Earnings-$1,708,586-$1,739,334-$1,735,086-$1,694,072
AOCI$2,270,182$2,230,176$1,857,004$1,849,898
Other Equity-$2,435-$2,374-$2,261-$2,260
Total Equity$561,596$490,842$121,918$155,826
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$822,101$714,327$288,345$348,936
Net Debt-$558,275-$495,696-$186,987-$259,894